Participants 31 66 3
in children and adolescents with AD
Participants 366 442 6
f 30 subjects, between the ages of 8 and 18 with AD based on DSM IV criteria
Participants 1255 1273 3
risperidone group,
Participants 1341 1358 3
haloperidol group
Participants 1578 1589 4
Risperidone
Participants 1626 1637 4
haloperidol
Participants 1742 1758 4
children with AD
